Cite
HARVARD Citation
Kavanaugh, A. et al. (n.d.). THU0182 Monotherapy with the jak1-selective inhibitor filgotinib displays an anti-inflammatory biomarker profile in rheumatoid arthritis patients. Annals of the rheumatic diseases. pp. 270-271. [Online].